In conclusion, our study demonstrates that C-APPL1/A-APPL2 allele combination is associated with an increase NAFLD occurrence, with a more severe hepatic steatosis grade and with a reduced adiponectin cytoprotective effects on liver. This evidence concerns the gene APPL1 and metabolic dysfunction-associated steatotic liver disease.